职业经历

Dr. Daniel 的博士学位论文题为“Molecular Characterization of the Hsp70/Hsp90 Organizing Protein (Hop): Phosphorylation, Subcellular Localization and Interaction with Hsp90”。熟悉各种实验室和研究技巧，包括分子生物学技术、器官培养、永生化细胞系 (哺乳动物) 的组织培养、外源蛋白的重组和纯化、重组DNA、荧光共焦显微术、哺乳动物细胞瞬时转染、定点突变、单/双向凝胶电泳、化验、蛋白质印迹、表面等离子体共 振技术、薄层高压液相色谱法 (HPLC) 等。Dr. Daniel从2008年起加入Edanz Editing和理文编辑。

Dr. Daniel’s PhD thesis was “Molecular Characterization of the Hsp70/Hsp90 Organizing Protein (Hop): Phosphorylation, Subcellular Localization and Interaction with Hsp90”. Dr Daniel is familiar with all standard laboratory and research techniques including molecular biological techniques, organ culture, tissue culture of immortalized cell lines (mammalian), recombinant production and purification of heterologous proteins, recombinant DNA manipulation, confocal fluorescent microscopy, transient transfection of mammalian cells, site directed mutagenesis, one and two-dimensional gel electrophoresis, assay techniques, western blot analysis and surface plasmon resonance spectroscopy, thin layer and high pressure liquid chromatography (HPLC). Dr Daniel began as an editor with Edanz Editing and Liwen Bianji (Edanz Editing China) in 2008.

科研和编辑领域
变形性关节症、组织工程及细胞培养，测试、分析经验丰富。写作经验丰富、已著有大量期刊及科学报告。并担任了多个期刊的专家评审委员。2001年起成为理文编辑全职编辑。

职业经历
Dr. Mosi 的在博士生阶段主要研究糖基转移酶，包括通过使用改良培养基和抑制剂研究糖原磷酸化酶和环糊精糖基转移酶反应机理。Dr. Mosi 曾在制药研究领域里从事八年的高级研究工作。她进行过将金属酶抑制剂用于抗菌药物以及半胱氨酸蛋白酶抑制剂用于癌症治疗等全新研究。Dr. Mosi在酶学、基于受体的细胞生物学、药物新陈代谢、蛋白纯化和培养生产等领域均有所建树。此外，她还设计并规范了译制学术成果的系统和流程，熟知 FDA条款、GLP和GMP规范。Dr. Mosi是Drug Information Association（药品信息协会）、International Society for the Study of Xenobiotics（国际外源物研究学会）、Society for Biomolecular Screening（生物分子筛选学会）、American Society for Microbiology（美国微生物学会）以及 Canadian Society for Chemistry（加拿大化学会）等组织的正式成员。以第一作者的身份发表过10篇同行评审论文，并编辑过生物学、生物化学、化学以及药理学等领域的诸 多文章。目前，Dr. Mosi已经加入到Edanz Editing的编辑团队中。
 
Dr. Mosi’s PhD studies involved the mechanism of reaction of two alpha glycosyltransferases, glycogen phosphorylase and cyclodextrin glycosyltransferase, through the use of modified substrates and inhibitors. Dr. Mosi is a senior research scientist with 8 years experience in pharmaceutical drug research. She has developed and implemented novel assays for the purpose of the identification of inhibitors of metallo-enzymes as antibacterials and inhibitors of cysteine proteases for the treatment of cancer. Dr. Mosi has applied expertise in enzymology, receptor based cell biology, drug metabolism and protein purification and production. As well, she has designed and standardized systems and procedures for interpreting scientific results. She also has a sound knowledge of FDA guidelines and trained in GLP and GMP procedures. Dr. Mosi is a professional member of the Drug Information Association, International Society for the Study of Xenobiotics, Society for Biomolecular Screening, American Society of Microbiology, and the Canadian Society of Chemistry. As first author of 10 published, peer reviewed manuscripts, and as editor of numerous other papers in fields of biology, biochemistry, chemistry and pharmacology Dr. Mosi brings an extensive writing background to her editing work for Edanz Editing.

职业背景

Dr.Mahkdum 曾任 University College London 研究员，后在加利福尼亚州 UCSD Scripps Institute 从事博士后研究工作。从2000年开始，Dr.Mahkdum 一直从事医学写作和编辑工作，担任过多个职务，包括2005年至2007年间牛津 Elsevier的总编辑一职。Dr.Mahkdum 从2008年起开始为 Edanz Editing 和理文编辑 (Edanz Editing China) 工作。

Dr.Mahkdum was a research fellow at the University College London before becoming at Postdoctoral Research fellow at the Scripps Institute at UCSD in California. Since 2000 Dr Makhdum has been a medical writer and editor holding various positions including Managing Editor at Elsevier in Oxford from 2005 to 2007. Dr Makhdum began as an editor with Edanz Editing and Liwen Bianji(Edanz Editing China)in 2008.

职业经历
Dr. Smith 的博士论文标题为：“The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance”。 一直担任 Queen Mary, University of London 细胞与分子科学研究所研究助手，并着重于糖尿病及相关代谢疾病的生物化学的研究。同时担任 London Sport Institute 研究员。曾在 London School of Journalism 进修过与出版相关的编辑和设计课程，现为全职医学作者。Dr. Smith 在全球知名机构 Medicus International 任职期间，通过与多家著名制药公司合作的医学交流项目积累了大量的医学和科学交流经验。2006年起加入 Edanz，凭借着广泛的研究背景，通过医学交流帮助客户达到出版的目标。
 
Dr. Smith’s PhD thesis was entitled “The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance”. Dr. Smith has been a Research Assistant at the Queen Mary, University of London’s Institute  of Cellular and Molecular Sciences where he focused on the biochemistry of diabetes and related metabolic disorders. He has also been a Research Fellow at the London Sport Institute, part of Middlesex  University. Dr. Smith has studied editing and design skills in relation to publication at the London School of Journalism and is now a fulltime medical writer. Dr Smith has gained extensive experience in medical and scientific communications while he worked at the internationally recognised agency Medicus International, where he worked on a range of medical communications projects for several well known pharmaceutical companies. He joined the Edanz group in 2006, where he is able to apply his wide research background and expertise in the medical communications sector to assisting clients to achieve their publication goals.

职业经历
Brunker 女士具有二十余年生物医学领域稿件的编辑经验，包括向同行评审期刊投稿的文章、学位论文和学术文章、向美国监管机构（食品和药品管理局以及美国专利商标局）递交的申请材料；各种药物广告、网站内容、演讲稿、论文以及会议等场合所需的材料；同时还包括广泛的医学教学资料。她的硕士学位论文探讨了HIV+ CD4+ 细胞的凋亡。还曾参与过乳癌和环境医学的实验室工作。

Ms. Brunker has been editing biomedical documents for over two decades, including submissions to peer-reviewed journals; dissertations and other academic papers; applications to US regulatory agencies (the Food and Drug Administration and the Patent and Trademark Office); pharmaceutical advertisements of all types; Web site content; slide presentations, scripts and other support pieces for conferences and similar events; and a wide variety of medical education materials. Her master's thesis was on apoptosis in HIV+ CD4+ cells. She has also done laboratory work in breast cancer and environmental medicine.

编辑领域
生化学、微生物学、医药学、毒理学、药理学、肿瘤学、传染病学、HIV/AIDS、糖尿病学、心脏病学等

职业经历

Dr. Lodge 是一名细胞生物学家，在学术和制药领域都具有一定的研究经验。博士和博士后就读阶段，他主要研究神经系统发育过程中肌动蛋白细胞骨架和 细胞黏附分子对轴突导向的作用。Dr. Lodge 于2001年加入葛兰素史克 (GlaxoSmithKline) 公司，从事神经变性疾病和精神疾病的目标识别和确认工作，以及干细胞相关的药物研发战略的开发。他具有广泛的细胞生物、分子生物和蛋白质生化技术等方面的专业技能，在国际同行评审期刊上发表过多篇第一作者文章。Dr. Lodge 从2008年起开始为 Edanz Group 工作。

Dr. Lodge is a cell biologist with research experience in both academia and the pharmaceutical industry. For his PhD and postdoctoral work, he studied the roles of the actin cytoskeleton and cell adhesion molecules in axon guidance during nervous system development. Dr. Lodge joined GlaxoSmithKline in 2001, where he has been involved in target identification and validation initiatives for neurodegenerative and psychiatric diseases, and in developing drug discovery strategies involving stem cells. His technical expertise covers a broad spectrum of cell biology, molecular biology and protein biochemistry techniques. Dr. Lodge has published several first author publications in international peer-reviewed journals. He began editing for the Edanz Group in 2008.

职业经历

身为科学编辑，Dr. Susan Furness在医学、药理学、遗传学等众多学科领域内学术文章的摘要和索引编写方面有大量的工作经验。Dr. Susan Furness本人仍在积极地从事科研活动并且有研究论文发表，具有丰富的校对和出版编辑工作经验。

编辑领域

医学编辑、科学数据分析、摘要写作、数据库、临床研究、药理学、药品相关的统计学、电生理学、电活动与药物的关系、哺乳动物心脏心室细胞研究

编辑领域

制药学、药物研发、神经科学、生理学和药物学

职业经历

Dr. Apricó 的博士论文题为“[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters”。2003年至2005年间，Dr. Apricó在瑞典哥德堡大学 Arvid Carlsson Institute 与Dr. Michael Nilsson一起从事博士后研究工作，主要研究反应性星形胶质化的体外模式。2005年后，一直担任大学药理学和生理学的讲师工作。自2008年起，Dr. Apricó开始为Edanz Editing 和理文编辑工作。

Dr. Aprico's doctoral thesis was "[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters" . 2003 to 2005 DR Aprico held a Post-Doctoral position at Arvid Carlsson Institute, Göteborg, Sweden working with Dr. Michael Nilsson, investigating in vitro models of reactive astrogliosis. Since 2005, Dr Aprico has been a university lecturer in pharmacology and physiology. Dr Aprico began as an editor with Edanz Editing and Liwen Bianji(Edanz Editing China) in 2008.

职业经历
致力于生物医学研究，特别是医学和药品研究领域。是一位富有经验的科学家，并为Lancet 杂志执笔，2005年成为理文编辑资深生物医学编辑，并且是很多医药公司及信息服务的文摘和索引编辑。
编辑领域
药理学、传染病、肿瘤学、微生物学、内分泌学
Dr. Kerr is a widely published author and reviewer in the field of biomedical research, particularly in the areas of medical and drug information. Dr. Kerr is a widely experienced scientist and writer and has published as a reporter for the Lancet. Dr Kerr has joined Edanz Editing in 2005 and brings with him many years of experience as a biomedical copy editor, and as an abstracter and indexer for various drug companies and information services. Dr. Kerr edits in the Health and Life Sciences with a particular interest in the field of Gastroenterology.

职业经历

作为药剂师，Dr. Vocadlo 在生物技术公司从事了六年的药物化学和药品研发工作；曾经参与过化合物多步合成及光谱分析，包括实验设计、操作、化合物的分离、纯化和鉴定等研究工作。Dr. Vocadlo发表过第一作者论文，在科技论文写作和编辑方面经验丰富，2007年开始为Edanz Editing 工作。

编辑领域

应用化学、有机化学、药物化学、药理学和药物研制

编辑领域

生物化学、生物医学、药物比较、药物合成、药理学、毒性、药物治疗。 2006年开始担为理文编辑工作。

编辑领域

分子神经系统科学、生物化学、药理学、帕金森病

职业经历

Dr. Demarest 先后取得了心理学学士和纽约州立石溪大学博士学位。她一直致力于行为小鼠模型的神经系统科学和遗传学的研究。现任 The Scripps Research Institute 科学家。Dr. Demarest 从2008年起加入 Edanz Group。

Dr. Demarest received a BS in Psychology and a PhD in Neurobiology and Behavior from the State University of New York at Stony Brook. Her work has focused on the neuroscience and genetics of a behavioral mouse model. From her research she has authored several peer-reviewed papers. She is currently a staff scientist at The Scripps Research Institute. She joined Edanz Group as an editor in 2008.

职业经历
Dr. de Boo 是一名生理学家，主要研究胎儿生长和新陈代谢。她的博士论文题为“Aspects of Nitrogen Metabolism in Intrauterine Growth Restriction”— 主要探讨了发育迟缓的人类新生儿和绵羊胎儿的尿素循环代谢障碍问题。在攻读博士后期间，完成了通过补充荷尔蒙的方法，对胎儿宫内发育迟缓而进行的子宫内治疗的研究。Dr. de Boo 对于写作和编辑学术类和非学术类稿件都具有丰富的经验，现为全职编辑。

Dr. de Boo is a physiologist with a particular interest in fetal growth and metabolism. Her PhD thesis was entitled "Aspects of Nitrogen Metabolism in Intrauterine Growth Restriction" - focusing primarily on urea cycle disorders in growth restricted human neonates and fetal sheep. She has since completed a postdoctoral study on the development of intrauterine treatments for Intrauterine Growth Restriction by hormonal supplementation. Dr. de Boo has extensive experience in writing and editing both scientific and non-scientific manuscripts and is now a full-time freelance editor

职业经历

在生物医学摘要和索引编写方面具有专业的出版编辑经验，涉及广泛的学科领域，包括制药学、药剂学、药理学、全科医学、生物化学、分子生物学、保健管理和环境生物学。

编辑领域

全科医学、制药学、药理学、分子生物学和环境生物学

职业经历

Victor 女士目前是东京大学 Medical Genome Sciences 的博士研究生，主要研究一种快速检测儿科患者呼吸道和肠道致病菌群的新型诊断工具。她掌握大部分的实验室工作技巧，例如引物设计、限制酶消化、PAGE, PCR & RT-PCR、神经氨酸酶及血凝素定型、亲和性HPLC、SDS-PAGE以及凝胶电泳。她对生物科技产业兴趣浓厚，无论在学术研究领域还是行业应用方面都具备丰富的实践经验。Sylvia 女士从2008年起开始为 Edanz Editing 和理文编辑工作。

Ms Victor is currently a Doctor of Philosophy (Ph.D) candidate in Medical Genome Sciences, at Tokyo University and is working on a novel diagnostic tool for the rapid detection of respiratory and intestinal pathogens in pediatric patients. Ms Victor has a working knowledge of most laboratory techniques such as Primer design, Restriction enzyme digests, PAGE, PCR & RT-PCR, Neuraminidase and Hemagglutinin typing, Affinity HPLC, SDS-PAGE and Gel Electrophoresis. Her interest lies in the field of Bio-entrepreneurship and has experience in both the academic and commercial aspects of Science. Ms Victor began as an editor with Edanz Editing and Liwen Bianji (Edanz Editing China) in 2008.

职业经历

Dr. Shoemaker的学术研究领域是药理学和毒理学，着重于神经组织退化疾病、内分泌疾病和肠胃病学的研究。在她的博士研究阶段，她研究并发表了关于肌萎缩病理中的大麻CB2受体的引入。在Emory University攻读博士后期间，她主要研究糖尿病早期肠道神经轴突的病理生理学。Dr. Shoemaker是一位经验丰富的编辑，于2009年起加入Edanz Group。

Dr. Shoemaker's scientific background is in pharmacology and toxicology with a focus on neurodegenerative diseases, endocrine disorders and gastroenterology. For her Ph.D. she investigated and published on the involvement of the second cannabinoid receptor (CB2) in the pathology of amyotrophic lateral sclerosis. For her post-doctoral fellowship at Emory University, she studied the pathophysiology of enteric axons during the early stages of Diabetes. Dr. Shoemaker is an experienced editor and began working for the Edanz Group early in 2009.

Dr Wadsworth's scientific background is pharmacology/microbiology with a background in both basic and clinical research. Dr Wadsworth worked in areas of basic research at Temple University Hospital, Section of Infectious Diseases, as well as working on a clinical protocol and grant for the study of antibiotics on mitochondrial protein synthesis. Dr. Wadsworth's technical skills include fluorescence technology, microbiological and molecular biological techniques, sub-cellular fractionation and immunological techniques. She has written 20 peer reviewed articles, and prepared clinical protocols and informed consents for clinical trials. Dr Wadsworth began working as an editor for the Edanz Group in 2009.

Dr Potter is currently a general practitioner in Western Australia. Dr Potter's PhD was concerned with the long-term effects of homocysteine-lowering treatment with B-vitamins on vascular structure and function in stroke patients. Her thesis was submitted as publications. Dr Potter, an experienced clinician and researcher, began working with the Edanz Group in 2009.

职业经历

作为一名信息科学家，Smith 女士在生物医学和防御领域具有大量的科学写作经验，曾担任Thomson Scientific的生物医学编辑和索引编辑以及AWRE (英国原子武器研究院) 研究员，并曾在Defence Research Information Centre 的出版部门负责撰写和编辑防御领域相关的研究论文。除了在制药领域的经验外，Smith女士还在 Defence Nuclear Programme项目中熟练运用各种分析化学技术进行材料分析工作。Smith女士从2007年开始成为Edanz Editing 编辑一员。

Ms Smith is an information scientist with significant scientific writing experience in the biomedical and defence fields. She has been a biomedical editor and indexer for Thomson Scientific, and has worked as a scientific officer and researcher for the AWRE (Atomic Weapons Research Establishment, UK). She also managed the Defence Research Information Centre's publications section, writing and editing defence related research. As well as her experience in the pharmaceutical field, Ms Smith is proficient in using various analytical chemistry techniques to analyse materials used in the Defence Nuclear Programme. She began as an editor for Edanz Editing in 2007.

编辑领域

生物医学、制药学、核技术及防御问题